Review of the Drug Enforcement Administration’s Accounting of Drug Control Funding Fiscal Year 2025
- NARA ID
- review-drug-enforcement-administrations-accounting-drug-control-funding-fiscal-year-2025
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Audit
- Released
- 2026-02-05
- Slug
- doj-oig-review-drug-enforcement-administrations-accounting-drug-control-funding-fiscal-year-2025
- Indexed
- 2026-04-27 05:00:10
More from DOJ OIG — Drug Enforcement Administration
- Audit of the Drug Enforcement Administration's Prescription Drug Take Back Activities
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration (DEA) Executive Assistant for Misuse of Position, Prohibited Association with a Former DEA Confidential Source, and Soliciting and Accepting Gifts from the Former DEA Confidential Source
- Audit of the Drug Enforcement Administration’s Diversion Control Support Task Orders Awarded to Ocean Bay Information and Systems Management, LLC
- Review of the Drug Enforcement Administration's Accounting of Drug Control Funding Fiscal Year 2024
- Public Summary of the Addendum to the Audit of the Drug Enforcement Administration's Management and Oversight of its Confidential Source Program
- Audit of the Drug Enforcement Administration’s Use of Polygraphs in the Pre-employment and Foreign Vetting Processes
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.